MKMehroz Khan

Mehroz Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehroz Khan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Aamir Sohail

    Department of Biochemistry , Faculty of Biological Sciences , Quaid-i-Azam University , Islamabad , Pakistan , qau.edu.pk

    1 shared publication
  • Aleena Altaf

    Department of Biochemistry , Faculty of Biological Sciences , Quaid-i-Azam University , Islamabad , Pakistan , qau.edu.pk

    1 shared publication
  • Atif Ali Khan Khalil

    Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea

    1 shared publication
  • Imran Ullah

    Division of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Gyeongnam Province, Republic of Korea

    1 shared publication
  • Maimoona Arshad

    Department of Biochemistry , Faculty of Biological Sciences , Quaid-i-Azam University , Islamabad , Pakistan , qau.edu.pk

    1 shared publication
  • Muhammad Asim

    Department of Biochemistry , Faculty of Biological Sciences , Quaid-i-Azam University , Islamabad , Pakistan , qau.edu.pk

    1 shared publication

Latest Publications

  • Open Access

    Juglone Attenuates CCl₄‐Induced Hepatic Injury in Mice With Associated Modulation of Oxidative Stress and Inflammasome‐Related mRNA Expression

    by Aamir Sohail, Raza Sufyan, Muhammad Asim, Mehroz Khan, Aleena Altaf, Muhammad Ehsan Ul Haq, Maimoona Arshad, Atif Ali Khan Khalil, Imran Ullah

    Carbon tetrachloride–induced liver injury is a well‐established model of toxic hepatitis, characterized by marked oxidative and inflammatory damage. It remains a relevant experimental system because broadly effective therapeutic options are still limited. Juglone, a natural naphthoquinone derived from Reynoutria japonica , has demonstrated antioxidant and anti‐inflammatory potential. However, mouse evidence combining standard liver injury measures with stress‐ and cell‐death gene profiling remains limited. Building on juglone studies in injury and fibrosis, we tested juglone in a CCl 4 model. Male C57BL/6 mice were assigned to normal, vehicle, CCl₄, silymarin (200 mg/kg), and juglone (8 mg/kg) groups, and CCl₄ (in corn oil) was administered intraperitoneally. Endpoints included body weight, serum liver enzymes and lipid profile, H&E histology, and RT‐qPCR panels for inflammatory, pyroptosis‐associated, ER stress and autophagy‐linked, apoptotic, oxidative‐stress, and profibrotic transcripts. CCl₄ exposure was associated with weight loss, enzyme elevation, dyslipidemia, and architectural disruption, whereas juglone treatment was associated with improved biochemical indices and histology alongside coordinated downregulation of inflammatory/pyroptosis‐related transcripts (including Il-1β , Il-6 , Nlrp3 , and Gsdmd ) and moderation of ER stress/autophagy and apoptosis‐linked transcripts, with downregulation of profibrotic transcripts ( Acta2 , Mmp2 , and Tgfβ1 ). In this mouse CCl₄ model, juglone treatment was associated with reduced serum and tissue injury signatures together with changes in stress and inflammation‐linked transcriptional programs. Because the molecular findings are primarily based on RT‐qPCR, these results are best interpreted as gene‐level associations compatible with modulation of oxidative stress, inflammasome‐ and pyroptosis‐related mRNA expression, ER stress responses, apoptosis‐linked transcripts, and remodeling‐associated transcripts, rather than as confirmed pathway inhibition or established antifibrotic activity. These data support juglone as a hepatoprotective candidate and identify protein‐level and functional validation as important next steps.